Respiratory Adverse Events after LMA® Mask Removal in Children: A Randomized Trial Comparing Propofol to Sevoflurane

dc.contributor.authorKaram, Cynthia J.
dc.contributor.authorZeeni, Carine A.
dc.contributor.authorYazbeck-Karam, V. G.
dc.contributor.authorShebbo, Fadia
dc.contributor.authorKhalili, Amro F.
dc.contributor.authorAbi Raad, Sarah G.
dc.contributor.authorBeresian, Jean
dc.contributor.authorAouad, Marie T.
dc.contributor.authorKaddoum, Roland N.
dc.contributor.departmentAnesthesiology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:40:33Z
dc.date.available2025-01-24T11:40:33Z
dc.date.issued2023
dc.description.abstractBACKGROUND: The removal of the laryngeal mask airway (LMA®) in children may be associated with respiratory adverse events. The rate of occurrence of these adverse events may be influenced by the type of anesthesia. Studies comparing total intravenous anesthesia (TIVA) with propofol and sevoflurane are limited with conflicting data whether propofol is associated with a lower incidence of respiratory events upon removal of LMA as compared to induction and maintenance with sevoflurane. We hypothesized that TIVA with propofol is superior to sevoflurane in providing optimal conditions and improved patient's safety during emergence. METHODS: In this prospective, randomized, double-blind clinical trial, children aged 6 months to 7 years old were enrolled in 1 of 2 groups: the TIVA group and the sevoflurane group. In both groups, patients were mechanically ventilated. At the end of the procedure, LMAs were removed when patients were physiologically and neurologically recovered to a degree to permit a safe, natural airway. The primary aim of this study was to compare the occurrence of at least 1 respiratory adverse event, the prevalence of individual respiratory adverse events, and the airway hyperreactivity score following emergence from anesthesia between the 2 groups. Secondary outcomes included ease of LMA insertion, quality of anesthesia during the maintenance phase, hemodynamic stability, time to LMA removal, and incidence of emergence agitation. RESULTS: Children receiving TIVA with propofol had a significantly lower incidence (10.8.% vs 36.2%; relative risk, 0.29; 95% CI [0.14-0.64]; P =.001) and lower severity (P =.01) of respiratory adverse outcomes compared to the patients receiving inhalational anesthesia with sevoflurane. There were no statistically significant differences in secondary outcomes between the 2 groups, except for emergence agitation that occurred more frequently in patients receiving sevoflurane (P <.001). CONCLUSIONS: Propofol induction and maintenance exerted a protective effect on healthy children with minimal risk factors for developing perioperative respiratory complications, as compared to sevoflurane. © 2023 Lippincott Williams and Wilkins. All rights reserved.
dc.identifier.doihttps://doi.org/10.1213/ANE.0000000000005945
dc.identifier.eid2-s2.0-85133700102
dc.identifier.pmid35213484
dc.identifier.urihttp://hdl.handle.net/10938/29514
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofAnesthesia and Analgesia
dc.sourceScopus
dc.subjectAnesthesia, inhalation
dc.subjectAnesthetics, inhalation
dc.subjectAnesthetics, intravenous
dc.subjectChild
dc.subjectEmergence delirium
dc.subjectHumans
dc.subjectLaryngeal masks
dc.subjectMethyl ethers
dc.subjectPropofol
dc.subjectProspective studies
dc.subjectSevoflurane
dc.subjectDexamethasone
dc.subjectFentanyl
dc.subjectOndansetron
dc.subjectDimethyl ether
dc.subjectInhalation anesthetic agent
dc.subjectIntravenous anesthetic agent
dc.subjectAdverse device effect
dc.subjectAirway
dc.subjectAnesthesia induction
dc.subjectAnesthetic recovery
dc.subjectArticle
dc.subjectArtificial ventilation
dc.subjectBite
dc.subjectBreath holding
dc.subjectBronchospasm
dc.subjectBruxism
dc.subjectControlled study
dc.subjectCoughing
dc.subjectCryotherapy
dc.subjectDevice removal
dc.subjectDisease severity
dc.subjectDouble blind procedure
dc.subjectEmergence agitation
dc.subjectFemale
dc.subjectHuman
dc.subjectIncidence
dc.subjectInfant
dc.subjectIntravenous anesthesia
dc.subjectLarynx spasm
dc.subjectLaser surgery
dc.subjectMajor clinical study
dc.subjectMale
dc.subjectMinor surgery
dc.subjectNeedle phobia
dc.subjectOutcome assessment
dc.subjectPatient safety
dc.subjectPostoperative nausea and vomiting
dc.subjectPrevalence
dc.subjectProspective study
dc.subjectRandomized controlled trial
dc.subjectRespiratory tract disease
dc.subjectRisk factor
dc.subjectSchool child
dc.subjectSide effect
dc.subjectStrabismus surgery
dc.subjectUpper respiratory tract obstruction
dc.subjectVentilated patient
dc.subjectWakefulness
dc.subjectAdverse event
dc.subjectInhalation anesthesia
dc.subjectLaryngeal mask
dc.titleRespiratory Adverse Events after LMA® Mask Removal in Children: A Randomized Trial Comparing Propofol to Sevoflurane
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-5484.pdf
Size:
1019.09 KB
Format:
Adobe Portable Document Format

Collections